TABLE 1.

Baseline Clinical and Demographic Data of Parkinson Disease Patients

	Number	Age (years)	Sex Male:Female	Disease Duration (years)	UPDRS Off Score	H&Y Score	C-31 Score	NMSS Score	Samples Rate (%)	Adnexa Rate (%)	L-Dopa (mg/day)
Supplemented	19	72 ± 2	9:10	5 ± 1	26 ± 3	2 ± 0.2	17 ± 3	11 ± 1	54 ± 8	13 ± 3	270 ± 20
Untreated	14	72 ± 2	9:5	6 ± 1	16 ± 2	1 ± 0.2	8 ± 2	10 ± 1	40 ± 7	10 ± 4	180 ± 30
p-Value		0.98	0.2	0.62	0.11	0.01*	0.15	0.96	0.55	0.99	0.01*

Data are reported as mean±SE.

C-31, COMPASS-31; H&Y, Hoehn and Yahr scale; NMSS, Non-Motor Symptoms Scale; UPDRS, Unified Parkinson Disease Rating Scale.

^*Significant differences.